An unprecedented international investigation has analyzed nearly 500 cat tumors to uncover striking genetic parallels with human breast cancer. Researchers from leading oncology centers across North America, Europe, and Asia conducted comprehensive genomic sequencing, identifying over 200 cancer-associated genes conserved across cats, dogs, and humans.
The findings reveal that 85% of oncogenic mutations in feline mammary tumors directly correspond to those driving aggressive triple-negative breast cancer in humans. According to Dr. Sarah Chen, lead investigator at the Comparative Oncology Research Institute, these genetic similarities are particularly pronounced in aggressive breast cancers. The research extends beyond tumor analysis to examine treatment responses, demonstrating that cats with specific genetic profiles respond similarly to targeted therapies showing promise in human clinical trials.
This landmark study represents the largest comparative oncology investigation of its kind and could accelerate drug development timelines by 18-24 months, benefiting both human patients and veterinary medicine.
Read the full article on GMJ Newsroom.
Was this article helpful?
